Answers are grounded in this paper and cite their sources.
Cariprazine is an atypical dopamine receptor partial agonist antipsychotic available in the form of capsules. Although capsules are one of the most desirable routes of administration, there are certain situations (e. g., in an acute psychiatric setting, or when swallowing difficulties, or liquid shortages are present) when they cannot be administered. Therefore, alternative solutions like orodispersible tablets are needed. This study aimed to investigate the bioequivalence of a newly developed orodispersible tablet to the commercially available hard gelatine capsule of cariprazine 1.5 mg.
No takes yet. Share an insight, caveat, or question.
Meszár et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: